PDS Biotechnology Corp: 10-Q filed 2015-11-06

Name: PDS Biotechnology Corp: 10-Q filed 2015-11-06
Creator: PDS Biotechnology Corp

What PDS Biotechnology Corp reported in its quarterly report filed 2015-11-06 (fiscal Q3 2015): 25 published measures, 67 facts as tagged in accession 0001140361-15-039902.

This filing

Form: 10-Q (quarterly report)
Filed: 2015-11-06
Fiscal period: fiscal Q3 2015
Accession: 0001140361-15-039902 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PDS Biotechnology Corp filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2015-09-30	58,483,452	USD
At 2014-12-31	17,046,661	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2015-09-30	-50,643,768	USD
At 2014-12-31	-27,833,749	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2015-09-30	52,879,907	USD
At 2014-12-31	13,728,972	USD
At 2014-09-30	2,806,437	USD
At 2013-12-31	7,858,169	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-10,130,050	USD	92
2015-01-01 to 2015-09-30	-20,119,498	USD	273
2014-07-01 to 2014-09-30	-3,518,133	USD	92
2014-01-01 to 2014-09-30	-9,038,388	USD	273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	799,424	USD	273
2014-01-01 to 2014-09-30	265,150	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2015-09-30	-54,195,499	USD
At 2014-12-31	-29,818,918	USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Unit	Days
2015-07-01 to 2015-09-30	USD	92
2015-01-01 to 2015-09-30	USD	273
2014-07-01 to 2014-09-30	USD	92
2014-01-01 to 2014-09-30	USD	273

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2015-09-30	2,781,885	USD
At 2014-12-31	1,443,982	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	1,566,562	USD	273
2014-01-01 to 2014-09-30	1,030,215	USD	273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-8,484,860	USD	92
2015-01-01 to 2015-09-30	-17,627,438	USD	273
2014-07-01 to 2014-09-30	-3,560,349	USD	92
2014-01-01 to 2014-09-30	-9,176,825	USD	273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2015-09-30	55,597,327	USD
At 2014-12-31	15,441,997	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	213,021	USD	92
2015-01-01 to 2015-09-30	615,047	USD	273
2014-07-01 to 2014-09-30	47,972	USD	92
2014-01-01 to 2014-09-30	47,972	USD	273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2015-09-30	8,450,143	USD
At 2014-12-31	3,893,209	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2015-09-30	2,644,987	USD
At 2014-12-31	2,045,782	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	8,484,860	USD	92
2015-01-01 to 2015-09-30	17,627,438	USD	273
2014-07-01 to 2014-09-30	3,560,349	USD	92
2014-01-01 to 2014-09-30	9,176,825	USD	273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	6,507,972	USD	92
2015-01-01 to 2015-09-30	12,574,455	USD	273
2014-07-01 to 2014-09-30	2,418,915	USD	92
2014-01-01 to 2014-09-30	5,636,021	USD	273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2015-09-30	1,688,475	shares
At 2014-12-31	1,688,475	shares

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

Period	Value	Unit	Days
At 2015-09-30	6,000,000	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2015-09-30	104,240	USD
At 2014-12-31	160,682	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2015-09-30	3,590,222	USD
At 2014-12-31	1,582,162	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2015-09-30	339,203	USD
At 2014-12-31	307,629	USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	-11,957,618	USD	92
2015-01-01 to 2015-09-30	-24,376,581	USD	273
2014-07-01 to 2014-09-30	-3,882,799	USD	92
2014-01-01 to 2014-09-30	-10,120,495	USD	273

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2015-07-01 to 2015-09-30	1,976,888	USD	92
2015-01-01 to 2015-09-30	5,052,983	USD	273
2014-07-01 to 2014-09-30	1,141,434	USD	92
2014-01-01 to 2014-09-30	3,540,804	USD	273

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	38,360	USD	273
2014-01-01 to 2014-09-30	23,474	USD	273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2015-01-01 to 2015-09-30	-126,415	USD	273
2014-01-01 to 2014-09-30	704,471	USD	273

Inspect the source

Entity: PDS Biotechnology Corp / CIK 0001472091
Captured: 2026-09-20T09:07:40.584Z
SEC response SHA-256: 69e1cee7a201b49964a3008a5c2ec76eaaf5723c75824c2caf8a2c52d86edef2

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001472091.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))